0
ZIOPHARM Oncology, Inc Banner Image

ZIOPHARM Oncology, Inc

  • Ticker ZIOP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ZIOPHARM Oncology, Inc Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of in-licensed cancer drugs in North America. The company’s products under various clinical programs include Palifosfamide for the treatment of sarcoma, testicular cancer, head and neck cancer, lymphomas, and other solid tumors; Darinaparsin, an anti-mitochondrial compound for the treatmentMore of acute promyelocytic leukemia, a precancerous condition; and Indibulin, a novel orally available small molecular-weight inhibitor of tubulin polymerization, as well as develops novel DNA-based biotherapeutics.
ZIOPHARM Oncology, Inc

Most Recent Annual Report

ZIOPHARM Oncology, Inc MOST RECENT 2019 Annual Report and Form 10K

ZIOPHARM Oncology, Inc does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports